BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 10444462)

  • 21. Cholecystokinin receptors and vagal nerves in control of food intake in rats.
    Garlicki J; Konturek PK; Majka J; Kwiecien N; Konturek SJ
    Am J Physiol; 1990 Jan; 258(1 Pt 1):E40-5. PubMed ID: 2301570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Central and peripheral vagal transport of cholecystokinin binding sites occurs in afferent fibers.
    Moran TH; Norgren R; Crosby RJ; McHugh PR
    Brain Res; 1990 Aug; 526(1):95-102. PubMed ID: 2078822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chylomicron components activate duodenal vagal afferents via a cholecystokinin A receptor-mediated pathway to inhibit gastric motor function in the rat.
    Glatzle J; Wang Y; Adelson DW; Kalogeris TJ; Zittel TT; Tso P; Wei JY; Raybould HE
    J Physiol; 2003 Jul; 550(Pt 2):657-64. PubMed ID: 12766241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vagal afferent and efferent contributions to the inhibition of food intake by cholecystokinin.
    Moran TH; Baldessarini AR; Salorio CF; Lowery T; Schwartz GJ
    Am J Physiol; 1997 Apr; 272(4 Pt 2):R1245-51. PubMed ID: 9140026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological dissociation of responses to CCK and gastric loads in rat mechanosensitive vagal afferents.
    Schwartz GJ; McHugh PR; Moran TH
    Am J Physiol; 1994 Jul; 267(1 Pt 2):R303-8. PubMed ID: 8048636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Secretin activates vagal primary afferent neurons in the rat: evidence from electrophysiological and immunohistochemical studies.
    Li Y; Wu X; Yao H; Owyang C
    Am J Physiol Gastrointest Liver Physiol; 2005 Oct; 289(4):G745-52. PubMed ID: 15920018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of cholecystokinin (CCK 1) and serotonin (5-HT 3) receptors increases the discharge of pancreatic vagal afferents.
    Mussa BM; Sartor DM; Verberne AJ
    Eur J Pharmacol; 2008 Dec; 601(1-3):198-206. PubMed ID: 19026634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transport of cholecystokinin (CCK) binding sites in subdiaphragmatic vagal branches.
    Moran TH; Smith GP; Hostetler AM; McHugh PR
    Brain Res; 1987 Jul; 415(1):149-52. PubMed ID: 2441809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sensory signal transduction in the vagal primary afferent neurons.
    Li Y
    Curr Med Chem; 2007; 14(24):2554-63. PubMed ID: 17979708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electrophysiological and autoradiographical evidence for cholecystokinin A receptors on rat isolated nodose ganglia.
    Widdop RE; Krstew E; Mercer LD; Carlberg M; Beart PM; Jarrott B
    J Auton Nerv Syst; 1994; 46(1-2):65-73. PubMed ID: 8120343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of type A and type B CCK receptor binding sites in rat vagus nerve.
    Corp ES; McQuade J; Moran TH; Smith GP
    Brain Res; 1993 Sep; 623(1):161-6. PubMed ID: 8221086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The ghrelin pentapeptide inhibits the secretion of pancreatic juice in rats.
    Kapica M; Laubitz D; Puzio I; Jankowska A; Zabielski R
    J Physiol Pharmacol; 2006 Dec; 57(4):691-700. PubMed ID: 17229991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Duodenal acid-induced gastric relaxation is mediated by multiple pathways.
    Lu YX; Owyang C
    Am J Physiol; 1999 Jun; 276(6):G1501-6. PubMed ID: 10362654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vagal afferent-dependent cholecystokinin modulation of visceral pain requires central amygdala NMDA-NR2B receptors in rats.
    Wang EM; Li WT; Yan XJ; Chen X; Liu Q; Feng CC; Cao ZJ; Fang JY; Chen SL
    Neurogastroenterol Motil; 2015 Sep; 27(9):1333-43. PubMed ID: 26197883
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serotonin and cholecystokinin synergistically stimulate rat vagal primary afferent neurones.
    Li Y; Wu XY; Owyang C
    J Physiol; 2004 Sep; 559(Pt 2):651-62. PubMed ID: 15235095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Somatostatin inhibits pancreatic enzyme secretion at a central vagal site.
    Li Y; Owyang C
    Am J Physiol; 1993 Aug; 265(2 Pt 1):G251-7. PubMed ID: 8103634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intestinal lipid inhibits gastric emptying via CCK and a vagal capsaicin-sensitive afferent pathway in rats.
    Hölzer HH; Turkelson CM; Solomon TE; Raybould HE
    Am J Physiol; 1994 Oct; 267(4 Pt 1):G625-9. PubMed ID: 7943327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Response of the gastric vagal afferent activity to cholecystokinin in rats lacking type A cholecystokinin receptors.
    Kurosawa M; Bucinskaite V; Taniguchi T; Miyasaka K; Funakoshi A; Lundeberg T
    J Auton Nerv Syst; 1999 Jan; 75(1):51-9. PubMed ID: 9935269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gastric vagal afferent neuropathy following experimental spinal cord injury.
    Besecker EM; Blanke EN; Deiter GM; Holmes GM
    Exp Neurol; 2020 Jan; 323():113092. PubMed ID: 31697943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different affinity states of CCK(1) receptors on pancreatic acini and gastric smooth muscle in the rat.
    Kisfalvi K; Rácz G; Zsirka-Klein A; Pelosini I; Scarpignato C; Varga G
    J Physiol Paris; 2001; 95(1-6):391-8. PubMed ID: 11595465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.